Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Compumedics Ltd
ASX:CMP

Watchlist Manager
Compumedics Ltd Logo
Compumedics Ltd
ASX:CMP
Watchlist
Price: 0.255 AUD Market Closed
Market Cap: AU$50.9m
Write Note Create Alert Ask AI

Wall St Price Targets

CMP Price Targets Summary
Compumedics Ltd

Wall Street analysts forecast CMP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CMP is 0.816 AUD with a low forecast of 0.808 AUD and a high forecast of 0.84 AUD.

CMP Lowest Forecast
Wall Street Target
AU$0.808
217% Upside
CMP Average Forecast
Wall Street Target
AU$0.816
220% Upside
CMP Highest Forecast
Wall Street Target
AU$0.84
229% Upside
Lowest Forecast
Price Target
0.808 AUD
217% Upside
Average Forecast
Price Target
0.816 AUD
220% Upside
Highest Forecast
Price Target
0.84 AUD
229% Upside
Compumedics Ltd Competitors:
Price Targets
XPEL
Xpel Inc
27% Upside
XPEL
Xpel Inc
27% Upside

Revenue
Forecast

5% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
5% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 24%.

What are analyst estimates?

Gross Profit
Forecast

6% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
6% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Compumedics Ltd

Operating Income
Forecast

N/A
Past Growth
97% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
97% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Operating Income over the next 5 years is 97%.

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Continue CMP Research

Summary
CMP intrinsic value, competitors valuation, and company profile.
DCF Valuation
CMP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CMP stock valuation using valuation multiples.
Wall St Estimates
CMP price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CMP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CMP's stock price target?
Price Target
0.816 AUD

According to Wall Street analysts, the average 1-year price target for CMP is 0.816 AUD with a low forecast of 0.808 AUD and a high forecast of 0.84 AUD.

What is the Revenue forecast for Compumedics Ltd?
Projected CAGR
24%

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 24%.

What is the Operating Income forecast for Compumedics Ltd?
Projected CAGR
97%

The compound annual growth rate for Operating Income over the next 5 years is 97%.

Back to Top
ALPHA SPREAD
Follow us
Join 355,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett